1. The European Parliament and the Council of the European Union. Directive 2001/83/EC of the European Parliament and the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Off J Eur Union 2001;L(311):67–128.
2. Harding K, Mather SJ. Investigative clinical studies with radiopharmaceuticals. Nucl Med Commun 2007;28(1):1–2.
3. The European Parliament and the Council of the European Union. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off J Eur Union 2001;L(121):34–44.
4. Decristoforo C, Peñuelas I. Towards a harmonized radiopharmaceutical regulatory framework in Europe? Q J Nucl Med Mol Imaging 2009;53(4):394–401.
5. European Commission. EudraLex, Volume 4. Good manufacturing practice (GMP) guidelines. Annex 13: Investigational Medicinal Products. 2010. http://ec.europa.eu/health/files/eudralex/vol-4/2009_06_annex13.pdf . Accessed 1 June 2014.